Bsa (Ritonavir Tablets Usp 1)
Ritonavir Tablet
Product Images NDC 65162-061
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ritonavir (NDC 65162-061). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Description Formula (Ritonavir Tablets Usp 2)
60ct Label (Ritonavir Tablets Usp 3)
This text contains information about NDC 651 62-061-06, which is a bottle of Ritonavir tablets. The bottle has a warning that the seal should not be broken or missing, and the tablets should be taken with meals, whole and not crushed. The usual dosage information is available in the package insert, and the tablets should be stored below 30°C (86'F). It is advised not to expose the tablets to high humidity or store them for more than two weeks. The bottle should not be covered with the pharmacy label, and the package insert is provided with Rx only tear-off patient information. The tablets should not be taken with AREL. This medicine is distributed by Amneal Pharmaceuticals LLC.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
